Hotaling Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AWA
Hotaling Investment Management's PFE Position: Q4 2022 in Review
Hotaling Investment Management increased its Pfizer (PFE) stake by 0.1% in Q4 2022, buying an estimated $3.6K and bringing the position to 71,697 shares worth $3.67M. The position accounts for 1.66% of the portfolio, ranked #18.
Hotaling Investment Management first reported a position in PFE in Q4 2018 and has held it in 17 quarters since. The position peaked at $5.66M in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.
- Hotaling Investment Management held 71,697 shares of Pfizer worth $3.67M as of Q4 2022.
- Hotaling Investment Management bought 75 Pfizer shares in Q4 2022, an estimated $3.6K.
- Pfizer made up 1.66% of Hotaling Investment Management's portfolio in Q4 2022, its #18 holding.
- Hotaling Investment Management first reported a position in Pfizer in Q4 2018 and has held it in 17 quarters since.
- Hotaling Investment Management's Pfizer position peaked at $5.66M in Q4 2021.
- 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.
Based on Hotaling Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.